001     140674
005     20240321220843.0
024 7 _ |a 10.1016/j.jmb.2019.01.034
|2 doi
024 7 _ |a pmid:30711541
|2 pmid
024 7 _ |a 0022-2836
|2 ISSN
024 7 _ |a 1089-8638
|2 ISSN
024 7 _ |a altmetric:54814099
|2 altmetric
037 _ _ |a DZNE-2020-06996
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schilling, Judith
|0 P:(DE-2719)2810643
|b 0
|e First author
|u dzne
245 _ _ |a Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2019-04-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1685011861_32155
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Huntington's disease (HD) is caused by an expanded CAG repeat in the huntingtin (HTT) gene, translating into an elongated polyglutamine stretch. In addition to the neurotoxic mutant HTT protein, the mutant CAG repeat RNA can exert toxic functions by trapping RNA-binding proteins. While few examples of proteins that aberrantly bind to mutant HTT RNA and execute abnormal function in conjunction with the CAG repeat RNA have been described, an unbiased approach to identify the interactome of mutant HTT RNA is missing. Here, we describe the analysis of proteins that preferentially bind mutant HTT RNA using a mass spectrometry approach. We show that (I) the majority of proteins captured by mutant HTT RNA belong to the spliceosome pathway, (II) expression of mutant CAG repeat RNA induces mis-splicing in a HD cell model, (III) overexpression of one of the splice factors trapped by mutant HTT ameliorates the HD phenotype in a fly model and (VI) deregulated splicing occurs in human HD brain. Our data suggest that deregulated splicing is a prominent mechanism of RNA-induced toxicity in HD.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 1
542 _ _ |i 2019-04-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
542 _ _ |i 2019-02-02
|2 Crossref
|u http://creativecommons.org/licenses/by-nc-nd/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Huntingtin Protein: genetics
|2 MeSH
650 _ 2 |a Huntington Disease: genetics
|2 MeSH
650 _ 2 |a RNA: genetics
|2 MeSH
650 _ 2 |a RNA Splicing: genetics
|2 MeSH
650 _ 2 |a Spliceosomes: genetics
|2 MeSH
700 1 _ |a Broemer, Meike
|0 P:(DE-2719)2810307
|b 1
|u dzne
700 1 _ |a Atanassov, Ilian
|b 2
700 1 _ |a Dürnberger, Yvonne
|0 P:(DE-2719)2810519
|b 3
|u dzne
700 1 _ |a Vorberg, Ina
|0 P:(DE-2719)2481765
|b 4
|u dzne
700 1 _ |a Dieterich, Christoph
|b 5
700 1 _ |a Dagane, Alina
|b 6
700 1 _ |a Dittmar, Gunnar
|b 7
700 1 _ |a Wanker, Erich
|b 8
700 1 _ |a van Roon-Mom, Willeke
|b 9
700 1 _ |a Winter, Jennifer
|b 10
700 1 _ |a Krauß, Sybille
|0 P:(DE-2719)2421562
|b 11
|e Last author
|u dzne
773 1 8 |a 10.1016/j.jmb.2019.01.034
|b : Elsevier BV, 2019-04-01
|n 9
|p 1869-1877
|3 journal-article
|2 Crossref
|t Journal of Molecular Biology
|v 431
|y 2019
|x 0022-2836
773 _ _ |a 10.1016/j.jmb.2019.01.034
|g Vol. 431, no. 9, p. 1869 - 1877
|0 PERI:(DE-600)1355192-9
|n 9
|q 431:9<1869 - 1877
|p 1869-1877
|t Journal of molecular biology
|v 431
|y 2019
|x 0022-2836
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/140674/files/DZNE-2020-06996.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/140674/files/DZNE-2020-06996.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:140674
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810643
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810307
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810519
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2481765
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)2421562
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 1
914 1 _ |y 2019
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-08
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MOL BIOL : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-08
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-08
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MOL BIOL : 2021
|d 2022-11-08
920 1 _ |0 I:(DE-2719)1011006
|k AG Krauß ; AG Krauß
|l Regulatory RNA-protein interaction in neurodegenerative diseases
|x 0
920 1 _ |0 I:(DE-2719)5000021
|k AG Brömer 1 ; AG Brömer 1
|l Ubiquitin-Mediated Processes in Neurodegenerative Diseases
|x 1
920 1 _ |0 I:(DE-2719)1013004
|k AG Vorberg
|l Prion Cell Biology
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1011006
980 _ _ |a I:(DE-2719)5000021
980 _ _ |a I:(DE-2719)1013004
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21